Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Multiple common disease pathogens refers to a broad and diverse group of infectious agents, including bacteria, viruses, fungi, and parasites, that are responsible for the majority of communicable human diseases (NIH, 2023). This entry does not describe a single molecular target, such as a specific receptor or enzyme, but rather serves as a collective descriptor for various organisms like Staphylococcus aureus, Influenza virus, and Candida albicans (StatPearls, 2023). These pathogens utilize distinct biological mechanisms to invade host tissues, evade immune detection, and replicate, leading to clinical manifestations of disease (Wikipedia, 2024). Therapeutic strategies are typically directed at specific molecular components within a single pathogen species, such as the bacterial cell wall or viral polymerases, rather than the group as a whole (PubMed, 2022). Because this term encompasses a vast range of biologically unrelated entities, it is considered an incorrect designation for a therapeutic target in the context of drug discovery and pharmacology.
Not applicable as this is a collective category of organisms rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple common disease pathogens.